CD46 Genetic Variability and HIV-1 Infection Susceptibility
No Thumbnail Available
Identifiers
Date
2021-11-01
Authors
Serrano-Risquez, Carmen
Omar, Mohamed
Amparo Gomez-Vidal, Maria
Miguel Real, Luis
Antonio Pineda, Juan
Rivero, Antonio
Rivero-Juarez, Antonio
Forthal, Donald
Marquez, Francisco J.
Lo Caputo, Sergio
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Mdpi
Abstract
CD46 is the main receptor for complement protein C3 and plays an important role in adaptive immune responses. CD46 genetic variants are associated with susceptibility to several infectious and autoimmune diseases. Additionally, CD46 function can be subverted by HIV-1 to evade attack by complement, a strategy shared by viruses of other families. We sought to determine the association between CD46 gene variants and HIV-1 acquired through intravenous drug use (IDU) and sexual routes (n = 823). Study subjects were of European ancestry and were HIV-1 infected (n = 438) or exposed but seronegative (n = 387). Genotyping of the rs2796265 SNP located in the CD46 gene region was done by allele-specific real-time PCR. A meta-analysis merging IDU and sexual cohorts indicates that the minor genotype (CC) was associated with increased resistance to HIV-1 infection OR = 0.2, 95% CI (0.07-0.61), p = 0.004. The HIV-1-protective genotype is correlated with reduced CD46 expression and alterations in the ratio of CD46 mRNA splicing isoforms.
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
HIV-1, HIV exposed seronegative, HESN, CD46, complement, Recombinant glycoprotein-120 vaccine, Complement regulatory proteins, Natural-resistance, Dendritic cells, Nitric-oxide, Receptor, Expression, Polymorphisms, Individuals, Association